JAZZ(Jazz Pharmaceuticals plc) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $3.09B | $3.66B | $3.83B | $4.07B | $4.27B |
| 毛利润 | — | — | — | — | — |
| 营业利润 | $170.28M | −$65.53M | $578.58M | $716.63M | −$430.24M |
| 净利润 | −$329.67M | −$224.06M | $414.83M | $560.12M | −$356.15M |
| 经营现金流 | $778.51M | $1.27B | $1.09B | $1.40B | $1.36B |
| 自由现金流 | $750.87M | $1.24B | $1.07B | $1.36B | $1.30B |
| 摊薄每股收益 | $-5.52 | $-3.58 | $6.10 | $8.65 | $-5.84 |